# Avantor Inc. (AVTR) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Healthcare / Life Science Tools. Price $15.59, market value $10.6 billion.

## Valuation
- **P/E (trailing): 31.2×** (5-yr avg 34.8×, 3-yr avg 34.4×). Avantor Inc. trades at 31.2× trailing earnings, close to its own five-year average of 34.8×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 17.6×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 1.6×**. Each dollar of revenue is priced at 1.6×.
- **Price / book: 1.8×**. The shares trade at 1.8× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 15.6×**. Enterprise value is 15.6× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 4.2%** (5-yr avg 4.8%). Free cash flow equals 4.2% of the market value, in line with its five-year average of 4.8%.
- **Earnings yield: 3.2%**. The inverse of the P/E: 3.2% of the price is earned each year.

## Profitability
- **Gross margin: 31.6%**. Avantor Inc. keeps 31.6% of revenue after the direct cost of what it sells.
- **Operating margin: 7.3%**. 7.3% of revenue is left after running the business.
- **Net margin: -8.1%**. The company reported a net loss over the last twelve months.
- **Return on equity: -9.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 4.2%**. Return on all capital, debt included, is 4.2%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 2.9%**. Each dollar of assets produces 2.9% of profit.

## Growth
- **Revenue growth (1 yr): -3.4%** (3-yr -4.5%/yr, 5-yr 0.5%/yr). Revenue fell 3.4% over the last year, against 0.5% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -175.0%**. Earnings per share fell 175.0%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): -11.3%/yr**. Free cash flow has compounded at -11.3% a year over three years.

## Financial health
- **Debt to equity: 0.71**. Debt is 0.71 times equity, moderate leverage.
- **Net debt / EBITDA: 4.0×**. It would take 4.0 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Current ratio: 1.78** (quick 1.78). Current assets cover the next year's liabilities 1.78 times.
- **Altman Z-score: 2.27**. A Z-score of 2.27 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Avantor Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (13 analysts). 13 analysts cover Avantor Inc.; the consensus is hold, with an average price target of $17.35 (+11% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 33.5%** (YTD 36.0%, 3-mo 14.0%). The shares are up 33.5% over twelve months including dividends.
- **From 52-week high: -10.7%** (114.6% above the low). Trading 11% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 0.86** (volatility 43%). Beta of 0.86 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AVTR · Page: https://foliofundamentals.com/stocks/avtr

Not investment advice.